The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

BackgroundThe association of pro-inflammatory markers such as interleukin-6 (IL-6) and other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest, however their kinetics, response to current COVID-related treatments, association with disease severity and comparison wi...

Full description

Bibliographic Details
Main Authors: Ana Copaescu, Fiona James, Effie Mouhtouris, Sara Vogrin, Olivia C. Smibert, Claire L. Gordon, George Drewett, Natasha E. Holmes, Jason A. Trubiano
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
interleukin-6
C-reactive protein
cytokine storm
Staphylococcus aureus bacteraemia
sepsis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.646095/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.646095/full

Similar Items